APA

Graff J. R., Konicek B. W., Lynch R. L., Dumstorf C. A., Dowless M. S., McNulty A. M., Parsons S. H., Brail L. H., Colligan B. M., Koop J. W., Hurst B. M., Deddens J. A., Neubauer B. L., Stancato L. F., Carter H. W., Douglass L. E. & Carter J. H. (20090714). eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. : Cancer research.

Chicago

Graff Jeremy R, Konicek Bruce W, Lynch Rebecca L, Dumstorf Chad A, Dowless Michele S, McNulty Ann M, Parsons Stephen H, Brail Leslie H, Colligan Bruce M, Koop Jonathan W, Hurst Bernadette M, Deddens James A, Neubauer Blake L, Stancato Louis F, Carter Harry W, Douglass Larry E and Carter Julia H. 20090714. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. : Cancer research.

Harvard

Graff J. R., Konicek B. W., Lynch R. L., Dumstorf C. A., Dowless M. S., McNulty A. M., Parsons S. H., Brail L. H., Colligan B. M., Koop J. W., Hurst B. M., Deddens J. A., Neubauer B. L., Stancato L. F., Carter H. W., Douglass L. E. and Carter J. H. (20090714). eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. : Cancer research.

MLA

Graff Jeremy R, Konicek Bruce W, Lynch Rebecca L, Dumstorf Chad A, Dowless Michele S, McNulty Ann M, Parsons Stephen H, Brail Leslie H, Colligan Bruce M, Koop Jonathan W, Hurst Bernadette M, Deddens James A, Neubauer Blake L, Stancato Louis F, Carter Harry W, Douglass Larry E and Carter Julia H. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. : Cancer research. 20090714.